Form 8-K - Current report:
SEC Accession No. 0001104659-20-113428
Filing Date
2020-10-08
Accepted
2020-10-08 16:11:04
Documents
8
Period of Report
2020-10-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2032790d1_8k.htm 8-K 26587
2 EXHIBIT 1.1 tm2032790d1_ex1-1.htm EX-1.1 245682
3 EXHIBIT 5.1 tm2032790d1_ex5-1.htm EX-5.1 9043
4 EXHIBIT 99.1 tm2032790d1_ex99-1.htm EX-99.1 9548
5 EXHIBIT 99.2 tm2032790d1_ex99-2.htm EX-99.2 9946
6 GRAPHIC tm2032790d1_ex5-1img001.jpg GRAPHIC 5690
7 GRAPHIC tm2032790d1_ex99-1img001.jpg GRAPHIC 8088
8 GRAPHIC tm2032790d1_ex99-1img002.jpg GRAPHIC 8088
  Complete submission text file 0001104659-20-113428.txt   332580
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39044 | Film No.: 201231090
SIC: 2836 Biological Products, (No Diagnostic Substances)